Flexor Hallucis Longus Training and Balance-Gait in Geriatrics
Launched by LOKMAN HEKIM ÜNIVERSITESI · Mar 13, 2025
Trial Information
Current as of April 30, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a specific exercise program can help improve the strength of a muscle in the foot called the flexor hallucis longus (FHL) in older adults. The focus is on seeing if strengthening this muscle can help with balance, walking, and reduce the risk of falls, which is a common concern for people over 65.
To participate, individuals need to be over the age of 65 and able to walk independently for at least 10 meters. They should also have no serious health issues that would prevent them from exercising, like severe joint problems or certain neurological conditions. Participants will be divided into three groups: one will do exercises with a trainer, another will exercise at home, and the last group will not do any exercises during the study. Throughout the trial, various tests will measure their strength, balance, and walking ability. This study aims to gather important information on how exercise can improve safety and mobility in older adults.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals over the age of 65,
- • Individuals who do not have hearing or speech problems,
- • Individuals who do not have any neurological, orthopedic or visual problems that would prevent walking (can walk 10 meters independently)
- • Individuals who score 24 points and above in the Mini Mental Test evaluation.
- Exclusion Criteria:
- • Those who cannot walk independently,
- • Those with serious musculoskeletal system disorders,
- • Those with hallux rigidus deformity,
- • Those with orthostatic hypotension,
- • Those who have difficulty understanding instructions and those with diabetic neuropathy.
About Lokman Hekim üniversitesi
Lokman Hekim Üniversitesi is a distinguished academic institution dedicated to advancing healthcare through innovative research and clinical trials. Committed to fostering a collaborative environment, the university integrates cutting-edge scientific inquiry with practical applications to enhance patient care and outcomes. With a focus on interdisciplinary approaches, Lokman Hekim Üniversitesi actively engages in partnerships with healthcare professionals and industry leaders to drive forward-thinking solutions in medical science. Their clinical trials aim to contribute valuable insights to the global medical community, ensuring the highest standards of ethical conduct and rigor in research practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Samsun, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported